{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:44:03Z","timestamp":1794005043611,"version":"4.8.0"},"reference-count":55,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The undesired prognosis of biliary tract cancer is mainly attributed to the difficulty in detecting cancer lesions, including intraepithelial neoplasia, and other hurdles in procuring sufficient pathological samples by forceps biopsy and brushing, or even their combination. However, the transpapillary approach under endoscopic retrograde cholangiopancreatography (ERCP) is the mainstream approach for the work-up and treatment of biliary tract diseases, especially biliary tract cancers, because the ERCP-guided approach efficiently enables simultaneous biliary drainage for the treatment of cholangitis\/jaundice and specimen acquisition for the diagnosis of biliary tract lesions. To improve diagnostic accuracy, several studies have been conducted on the feasibility and efficacy of genomic analysis of endoscopic specimens, namely, brushing samples, forceps biopsy samples, and aspiration samples such as bile with sensitivities ranging from 47 to 100%, with specificities ranging from 69 to 100%. Clinical use of genomic analysis remains heterogeneous due to the panel and next-generation sequencing system. For the efficient and precise treatment of patients with biliary tract cancer, future diagnosis and treatment should be based on molecular and genetic analyses. In this article, we review and summarize the comprehensive gene panel analyses of transpapillary brushing\/biopsy\/aspiration specimens for biliary tract cancer using next-generation sequencing, promoting effective clinical practice and providing a basis for future studies.<\/jats:p>","DOI":"10.3390\/diagnostics16101516","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:56:27Z","timestamp":1779094587000},"page":"1516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Gene Panel Analysis of Biliary Tract Cancer Using Next-Generation Sequencing of Endoscopic Transpapillary Brushing\/Biopsy\/Aspiration Specimens: A Narrative Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-6068","authenticated-orcid":false,"given":"Masaki","family":"Kuwatani","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Hospital, North 14, West 5, Kita-ku, Sapporo 060-8648, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Hospital, North 14, West 5, Kita-ku, Sapporo 060-8648, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"ref_1","unstructured":"National Cancer Center Japan (2026, January 12). Cancer Registry and Statistics; Cancer Information Service. Available online: https:\/\/ganjoho.jp\/public\/qa_links\/report\/statistics\/2025_en.html."},{"key":"ref_2","unstructured":"National Cancer Institute Surveillance (2026, January 12). Epidemiology, and End Results (SEER) Program, Available online: https:\/\/seer.cancer.gov\/."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"ASGE Standards of Practice Committee, Chandrasekhara, V., Khashab, M.A., Muthusamy, V.R., Acosta, R.D., Agrawal, D., Bruining, D.H., Eloubeidi, M.A., Fanelli, R.D., and Faulx, A.L. (2017). Adverse events associated with ERCP. Gastrointest. Endosc., 85, 32\u201347.","DOI":"10.1016\/j.gie.2016.06.051"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/a-1075-4080","article-title":"ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"52","author":"Dumonceau","year":"2020","journal-title":"Endoscopy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2024.10.033","article-title":"Adverse events associated with endoscopic retrograde cholangiopancreatography: Systematic review and meta-analysis","volume":"168","author":"Bishay","year":"2025","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e70141","DOI":"10.1111\/den.70141","article-title":"Advances in Diagnosis and Treatment with Cholangiopancreatoscopy","volume":"38","author":"Ogura","year":"2026","journal-title":"Dig. Endosc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0016-5107(95)70012-9","article-title":"Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: Results of a prospective study","volume":"42","author":"Ponchon","year":"1995","journal-title":"Gastrointest. Endosc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0016-5107(95)70004-8","article-title":"Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: A prospective study","volume":"42","author":"Pugliese","year":"1995","journal-title":"Gastrointest. Endosc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1756283X14564674","article-title":"Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma","volume":"8","author":"Nanda","year":"2015","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1751-2980.12311","article-title":"Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy","volume":"17","author":"Naitoh","year":"2016","journal-title":"J. Dig. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.gie.2014.09.017","article-title":"Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: A systematic review and meta-analysis","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest. Endosc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3748\/wjg.14.1097","article-title":"Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma","volume":"14","author":"Weber","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) clinical guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5009\/gnl13292","article-title":"Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma","volume":"8","author":"Lee","year":"2014","journal-title":"Gut Liver"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"viii205","DOI":"10.1093\/annonc\/mdy282","article-title":"Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA)","volume":"29","author":"Sakai","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: A multicentre, open-label, phase 2 study","volume":"21","author":"Sahai","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103488","DOI":"10.1016\/j.esmoop.2024.103488","article-title":"An open-label study of pemigatinib in cholangiocarcinoma: Final results from FIGHT-202","volume":"9","author":"Vogel","year":"2024","journal-title":"ESMO Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, Ascot): A multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): A randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s10038-019-0658-5","article-title":"A new era of long-read sequencing for cancer genomics","volume":"65","author":"Sakamoto","year":"2020","journal-title":"J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmoldx.2018.09.007","article-title":"A novel multiplex droplet digital PCR assay to identify and quantify KRAS mutations in clinical specimens","volume":"21","author":"Alcaide","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1245\/s10434-025-17292-y","article-title":"Risk of malignancy for indeterminate cytology of bile duct strictures: A systematic review and meta-analysis","volume":"32","author":"Lieb","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jmoldx.2015.08.002","article-title":"Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary brushings for malignancy","volume":"18","author":"Dudley","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gutjnl-2018-317817","article-title":"Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures","volume":"69","author":"Singhi","year":"2020","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jasc.2020.06.009","article-title":"Cytomorphologic characteristics of next-generation sequencing-positive bile duct brushing specimens","volume":"9","author":"Rosenbaum","year":"2020","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41379-020-0577-1","article-title":"Tiny but mighty: Use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis","volume":"33","author":"Harbhajanka","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cncy.22528","article-title":"Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis","volume":"130","author":"Scheid","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.gie.2022.10.014","article-title":"Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis","volume":"97","author":"Kamp","year":"2023","journal-title":"Gastrointest. Endosc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e0415","DOI":"10.1097\/HC9.0000000000000415","article-title":"NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study","volume":"8","author":"Boyd","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Park, W., Gwack, J., and Park, J. (2024). Implementing massive parallel sequencing into biliary samples obtained through endoscopic retrograde cholangiopancreatography for diagnosing malignant bile duct strictures. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179461"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gutjnl-2021-325178","article-title":"Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures","volume":"71","author":"Arechederra","year":"2021","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: Somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/gutjnl-2022-327099","article-title":"Clinical relevance of biomarkers in cholangiocarcinoma: Critical revision and future directions","volume":"71","author":"Macias","year":"2022","journal-title":"Gut"},{"key":"ref_37","first-page":"PO.17.00011","article-title":"OncoKB: A precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: The ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","article-title":"Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Chiorean","year":"2023","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","article-title":"NCCN Guidelines\u00ae insights: Biliary tract cancers, version 2.2023","volume":"21","author":"Benson","year":"2023","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41424-018-0015-6","article-title":"Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma","volume":"9","author":"Bankov","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/path.4576","article-title":"The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing","volume":"237","author":"Wood","year":"2015","journal-title":"J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng.3357","article-title":"Whole-genome sequencing provides new insights into the clonal architecture of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"47","author":"Becq","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Fukuda, S., Hijioka, S., Nagashio, Y., Yamashige, D., Agarie, D., Hagiwara, Y., Okamoto, K., Yagi, S., Komori, Y., and Kuwada, M. (2024). Utility of transpapillary biopsy and endoscopic ultrasound-guided tissue acquisition for comprehensive genome profiling of unresectable biliary tract cancer. Cancers, 16.","DOI":"10.3390\/cancers16162819"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.32074\/1591-951X-1117","article-title":"Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures","volume":"117","author":"Vasuri","year":"2025","journal-title":"Pathologica"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.gie.2025.06.042","article-title":"Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: A randomized, noncomparative trial","volume":"103","author":"Ishiwatari","year":"2026","journal-title":"Gastrointest. Endosc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/15384047.2018.1456604","article-title":"Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer","volume":"19","author":"Kinugasa","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Driescher, C., Fuchs, K., Haeberle, L., Goering, W., Frohn, L., Opitz, F.V., Haeussinger, D., Knoefel, W.T., Keitel, V., and Esposito, I. (2020). Bile-based cell-free DNA analysis is a reliable diagnostic tool in pancreatobiliary cancer. Cancers, 13.","DOI":"10.3390\/cancers13010039"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Nagai, K., Kuwatani, M., Hirata, K., Suda, G., Hirata, H., Takishin, Y., Furukawa, R., Kishi, K., Yonemura, H., and Nozawa, S. (2022). Genetic analyses of cell-free DNA in pancreatic juice or bile for diagnosing pancreatic duct and biliary tract strictures. Diagnostics, 12.","DOI":"10.3390\/diagnostics12112704"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jhbp.1432","article-title":"The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancer","volume":"31","author":"Miura","year":"2024","journal-title":"J. Hepato-Bil. Pancreat. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1111\/cas.16365","article-title":"Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers","volume":"115","author":"Ito","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gie.2024.12.024","article-title":"Next-generation sequencing improves the detection of malignant biliary strictures and changes management","volume":"102","author":"Bardhi","year":"2025","journal-title":"Gastrointest. Endosc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e70049","DOI":"10.1111\/liv.70049","article-title":"Mutational analysis of bile cell-free DNA in primary sclerosing cholangitis: A pilot study","volume":"45","author":"Arechederra","year":"2025","journal-title":"Liver Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"101253","DOI":"10.1016\/j.mam.2024.101253","article-title":"Principles of digital sequencing using unique molecular identifiers","volume":"96","author":"Andersson","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJMoa2508820","article-title":"Phase 1 study of Rezatapopt, a p53 reactivator, in TP53 Y220C-mutated tumors","volume":"394","author":"Dumbrava","year":"2026","journal-title":"N. Engl. J. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:33:53Z","timestamp":1779096833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diagnostics16101516"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16101516","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}